AZN vs KSS · P/E 28, $288.38B cap vs P/E 6.5, rev $6.68B
AstraZeneca PLC (AZN) versus Kohl's Corporation (KSS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Kohl's Corporation (KSS) is a department stores company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported KSS revenue for 2026-08-01 was $6.68B. Net income was $137.0M. KSS currently screens at market cap $1.74B and trailing P/E 6.5.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. KSS currently screens at market cap $1.74B and trailing P/E 6.5.
Not investment advice. Open the AZN and KSS stock pages for the full models.
Not investment advice.